Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis

Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis

Background:. Antiviral therapy is not indicated for patients with chronic hepatitis B (CHB) in the immune-tolerant (IT) phase. We compared the outcomes between the untreated IT phase and the treated immune-active (IA) phase in noncirrhotic HBeAg-positive CHB patients. Methods:. We systematically sea...

Full description

Bibliographic Details
Main Authors:	Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2023-02-01
Series:	Hepatology Communications
Online Access:	http://journals.lww.com/10.1097/HC9.0000000000000011

Similar Items

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
by: Jeong-Ju Yoo, et al.
Published: (2023-04-01)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
by: Mi Young Jeon, et al.
Published: (2021-04-01)

Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
by: Xuwei Wu, et al.
Published: (2023-02-01)

Idiopathic Noncirrhotic Portal Hypertension: An Appraisal
by: Hwajeong Lee, et al.
Published: (2016-01-01)

Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
by: Chang Woo Shim, et al.
Published: (2017-07-01)

Noncirrhotic Portal Vein Thrombosis Presenting with Hepatic Encephalopathy Due to Polycythemia Vera and MRI Findings
by: Burcu GÖKÇE ÇOKAL, et al.
Published: (2017-04-01)

Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B
by: Young Mi Hong, et al.
Published: (2022-04-01)

Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient
by: Yao-Kuang Wang, et al.
Published: (2013-12-01)

Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal Hypertension
by: Ohad Etzion, et al.
Published: (2018-08-01)

Splenic Marginal Zone Lymphoma in the Setting of Noncirrhotic Portal Hypertension
by: Saman Ratnayake MD, et al.
Published: (2015-09-01)

Challenging liver lesions in noncirrhotic patients: Report of three cases
by: Tania Franceschini, et al.
Published: (2019-05-01)

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
by: Joo Hyun Oh, et al.
Published: (2023-04-01)

A cost-effectiveness analysis of shortened direct-acting antiviral treatment in genotype 1 noncirrhotic treatment-naive patients with chronic hepatitis C virus
by: Fawsitt, C, et al.
Published: (2019)

The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
by: Moon Haeng Hur, et al.
Published: (2023-04-01)

Noncirrhotic portal hypertension misdiagnosed as liver cirrhosis: A rare case
by: Lingling Yang, et al.
Published: (2023-03-01)

Adult‐onset noncirrhotic hyperammonemic encephalopathy probably caused by splenorenal shunts
by: Kazuhiro Yoshizawa, et al.
Published: (2022-04-01)

Noncirrhotic portal hypertension: Another cause of liver disease in HIV patients
by: Manuel Mendizabal, et al.
Published: (2009-10-01)

Noncirrhotic hyperammonemia: A factor behind dementia to alter mental status
by: Christopher Leo, et al.
Published: (2019-11-01)

Hepatocellular carcinoma in the noncirrhotic liver: Clinical features and outcomes in Veracruz, Mexico
by: G. Martínez-Mier, et al.
Published: (2021-01-01)

Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis.
by: Young Eun Chon, et al.
Published: (2012-01-01)

Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
by: Haneulsaem Shin, et al.
Published: (2019-12-01)

A case report of a teenager with hepatitis B surface antigen‐positive multifocal hepatocellular carcinoma in a noncirrhotic liver
by: Kwadwo Apeadu Danso, et al.
Published: (2022-03-01)

Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimize treatment outcome in genotype 1 noncirrhotic treatment-naïve patients with chronic hepatitis C virus
by: Fawsitt, C, et al.
Published: (2019)

Hepatocellular Carcinoma in Cirrhotic Versus Noncirrhotic Livers: Clinicomorphologic Findings and Prognostic Factors
by: Ümit Karaoğullarından, et al.
Published: (2023-03-01)

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
by: Jeong-Ju Yoo, et al.
Published: (2023-04-01)

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
by: Halil Haldun Emiroglu
Published: (2023-07-01)

Are the Patients in the Immune Tolerant Phase of Chronic Hepatitis B far from Hepatocellular Carcinoma or Death?
by: Nae-Yun Heo
Published: (2019-07-01)

Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
by: Patrick T. F. Kennedy, et al.
Published: (2017-04-01)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
by: David Sooik Kim, et al.
Published: (2019-09-01)

Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver—A Single Centre Study
by: Lea Penzkofer, et al.
Published: (2022-09-01)

Portosystemic Encephalopathy in a Noncirrhotic Patient Treated by Vascular Plug Embolization of Mesoiliac Shunt
by: Othman Alshehre, et al.
Published: (2020-01-01)

Histologic changes in immune-tolerant patients with chronic hepatitis B: a systematic review and meta-analysis
by: Zhiguo Li, et al.
Published: (2023-01-01)

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
by: Joo Hyun Oh, et al.
Published: (2023-07-01)

Transhepatic embolization of a congenital intrahepatic portosystemic shunt for the treatment of hepatic encephalopathy in a noncirrhotic patient using Amplatzer vascular plug device
by: Rachel Ann Brader, BS, et al.
Published: (2017-06-01)

Clinicohistological correlation of etiological spectrum of chronic liver disease diagnosed during noncirrhotic stages in children: Can need of liver biopsy be obviated?
by: Tryambak Samanta, et al.
Published: (2021-01-01)

Transjugular Intrahepatic Portosystemic Shunt in Nonmalignant Noncirrhotic Portal Vein Thrombosis and Portosinusoidal Vascular Disorder
by: Sarah Shalaby, et al.
Published: (2024-02-01)

Hepatocellular Carcinoma in a Noncirrhotic Liver after Long-Term Use of Danazol for Hereditary Angioedema
by: Soraya Rahal, et al.
Published: (2014-12-01)

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
by: Han Ah Lee, et al.
Published: (2016-09-01)

Hypermethylation of the glutathione peroxidase 4 gene promoter is associated with the occurrence of immune tolerance phase in chronic hepatitis B
by: Xing Su, et al.
Published: (2024-03-01)